Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data.
Choi J, Choi CM, Chang YS, Lee KY, Kim SJ, Yang SH, Ryu JS, Lee JE, Lee SY, Park JY, Kim YC, Oh IJ, Jung CY, Lee SH, Yoon SH, Lee SY, Jang TW.
Choi J, et al. Among authors: oh ij.
Transl Lung Cancer Res. 2023 Nov 30;12(11):2275-2282. doi: 10.21037/tlcr-23-383. Epub 2023 Nov 28.
Transl Lung Cancer Res. 2023.
PMID: 38090523
Free PMC article.